REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

NARecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

January 31, 2029

Conditions
Ovarian CancerAdvanced Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal CancerPARP InhibitorFatigue Related to Cancer TreatmentFatigue in Cancer Survivors
Interventions
BEHAVIORAL

REVITALIZE Intervention

A remotely delivered tele-health intervention to address cancer fatigue that is based on an acceptance-based approach. The intervention includes 8 one-on-one weekly sessions and 2 booster sessions with trained psychology doctoral students based at University of Colorado. Sessions will focus on fatigue education, Acceptance and Commitment Therapy (ACT) skills, and behavior changes. Wi-Fi enabled tablets and keyboards will be provided to participants if needed. All sessions will be conducted via the Zoom platform and will either be videotaped or audiotaped.

BEHAVIORAL

Educational Materials

The educational materials arm will receive specialized cancer survivorship educational materials created by the National Cancer Institute

Trial Locations (6)

27710

ACTIVE_NOT_RECRUITING

Duke Cancer Center, Durham

80045

ACTIVE_NOT_RECRUITING

University of Colorado Cancer Center-Anschutz, Aurora

80309

RECRUITING

University of Colorado Boulder, Boulder

02114

RECRUITING

Massachusetts General Hospital-Cancer Center, Boston

02115

RECRUITING

Beth Israel Deaconess Medical Center, Boston

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER